GlassScriptPhysician profile
Nancy Mcconnell
NPI 1154384790
$6,163.67
in general payments reported to CMS, 2019-2025
58 companies · $850 in 2025
The $850 reported for 2025 was more than what 77% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,682 · 2022: $1,484 · 2023: $825 · 2024: $1,322 · 2025: $850.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,932 · Education: $64.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,932.07 |
| Education | $64.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,356.86 | 2021-2025 | |
| Novo Nordisk INC | $577.92 | 2021-2024 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $361.37 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Amgen INC. | $252.77 | 2021-2025 | Repatha, Otezla, Evenity |
| Astrazeneca Pharmaceuticals LP | $248.28 | 2021-2025 | Farxiga, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $246.79 | 2021-2025 | Jardiance |
| Astellas Pharma US INC | $244.55 | 2021-2024 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $242.64 | 2021-2025 | |
| Medtronic, INC. | $176.56 | 2021-2025 | Inceptiv |
| Pfizer INC. | $163.19 | 2021-2025 | |
| Glaxosmithkline, LLC. | $160.88 | 2021-2024 | Trelegy Ellipta, Shingrix |
| Boston Scientific Corporation | $138.57 | 2024-2025 | Watchman Access System, General - Therapies |
| Abbott Laboratories | $106.38 | 2021-2023 | Proclaim |
| Novartis Pharmaceuticals Corporation | $105.76 | 2021-2023 | |
| Sanofi-Aventis U.S. LLC | $99.15 | 2021-2025 |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Mcconnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.